Steven Cohen's NTLA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 398,463 shares of Intellia Therapeutics, Inc. (NTLA) worth $6.74 M, representing 0.01% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in NTLA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 270,011 shares. Largest reduction occurred in Q4 2020, reducing 507,619 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Intellia Therapeutics (NTLA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Intellia Therapeutics (NTLA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +128,452 | Add 47.57% | 398,463 | $16.92 |
| Q1 2026 | +270,011 | New Buy | 270,011 | $12.82 |
| Q4 2025 | -174,261 | Sold Out | 0 | $0.00 |
| Q3 2025 | +174,261 | New Buy | 174,261 | $17.27 |
| Q2 2021 | -180,400 | Sold Out | 0 | $0.00 |
| Q1 2021 | +34,900 | Add 23.99% | 180,400 | $80.25 |
| Q4 2020 | -507,619 | Reduce 77.72% | 145,500 | $54.40 |
| Q3 2020 | -217,788 | Reduce 25.01% | 653,119 | $19.88 |
| Q2 2020 | +870,907 | New Buy | 870,907 | $21.02 |
Steven Cohen's Intellia Therapeutics Investment FAQs
Steven Cohen first purchased Intellia Therapeutics, Inc. (NTLA) in Q2 2020, acquiring 870,907 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Intellia Therapeutics, Inc. (NTLA) for 9 quarters since Q2 2020.
Steven Cohen's largest addition to Intellia Therapeutics, Inc. (NTLA) was in Q2 2020, adding 870,907 shares worth $18.31 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 398,463 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $6.74 M.
As of the Q2 2026 filing, Intellia Therapeutics, Inc. (NTLA) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Intellia Therapeutics, Inc. (NTLA) was 870,907 shares, as reported at the end of Q2 2020.